|
1
|
Wennerberg AE, Nalesnik MA and Coleman WB:
Hepatocyte paraffin 1: a monoclonal antibody that reacts with
hepatocytes and can be used for differential diagnosis of hepatic
tumors. Am J Pathol. 143:1050–1054. 1993.
|
|
2
|
Porcell AI, De Young BR, Proca DM and
Frankel WL: Immunohistochemical analysis of hepatocellular and
adeno-carcinoma in the liver: MOC31 compares favorably with other
putative markers. Mod Pathol. 13:773–778. 2000. View Article : Google Scholar
|
|
3
|
Shirakawa H, Kuronuma T, Nishimura Y,
Hasebe T, Nakano M, Gotohda N, Takahashi S, Nakagohri T, Konishi M,
Kobayashi N, Kinoshita T and Nakatsura T: Glypican-3 is a useful
diagnostic marker for a component of hepatocellular carcinoma in
human liver cancer. Int J Oncol. 34:649–656. 2009.PubMed/NCBI
|
|
4
|
Herren B and Burrows PD: B cell-restricted
human mb-1 gene: expression, function, and lineage infidelity.
Immunol Res. 26:35–43. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Torres RM, Flaswinkel H, Reth M and
Rajewsky K: Aberrant B cell development and immune response in mice
with a compromised BCR complex. Science. 272:1804–1808. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chu PG and Arber DA: CD79: a review. Appl
Immunohistochem Mol Morphol. 9:97–106. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mason DY, Cordell JL, Brown MH, Borst J,
Jones M, Pulford K, Jaffe E, Ralfkiaer E, Dallenbach F, Stein H,
Pileri S and Gatter KC: CD79a: a novel marker for B-cell neoplasms
in routinely processed tissue samples. Blood. 86:1453–1459.
1995.PubMed/NCBI
|
|
8
|
Bhargava P, Kallakury BV, Ross JS, Azumi N
and Bagg A: CD79a is heterogeneously expressed in neoplastic and
normal myeloid precursors and megakaryocytes in an antibody
clone-dependent manner. Am J Clin Pathol. 128:306–313. 2007.
View Article : Google Scholar
|
|
9
|
Yu LM and Chang TW: Human mb-1 gene:
complete cDNA sequence and its expression in B cells bearing
membrane Ig of various isotypes. J Immunol. 148:633–637.
1992.PubMed/NCBI
|
|
10
|
Ng IO, Shek TW, Nicholls J and Ma LT:
Combined hepatocellularcholangiocarcinoma: a clinicopathological
study. J Gastroenterol Hepatol. 13:34–40. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yano Y, Yamamoto J, Kosuge T, Sakamoto Y,
Yamasaki S, Shimada K, Ojima H, Sakamoto M, Takayama T and Makuuchi
M: Combined hepatocellular and cholangiocarcinoma: a
clinicopathologic study of 26 resected cases. Jpn J Clin Oncol.
33:283–287. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jarnagin WR, Weber S, Tickoo SK, Koea JB,
Obiekwe S, Fong Y, DeMatteo RP, Blumgart LH and Klimstra D:
Combined hepatocellular and cholangiocarcinoma: demographic,
clinical, and prognostic factors. Cancer. 94:2040–2046. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tickoo SK, Zee SY, Obiekwe S, Xiao H, Koea
J, Robiou C, Blumgart LH, Jarnagin W, Ladanyi M and Klimstra DS:
Combined hepatocellular-cholangiocarcinoma: a histopathologic,
immunohistochemical, and in situ hybridization study. Am J Surg
Pathol. 26:989–997. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim H, Park C, Han KH, Choi J, Kim YB, Kim
JK and Park YN: Primary liver carcinoma of intermediate
(hepatocyte-cholangiocyte) phenotype. J Hepatol. 40:298–304. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fujii H, Zhu XG, Matsumoto T, Inagaki M,
et al: Genetic classification of combined
hepatocellular-cholangiocarcinoma. Hum Pathol. 31:1011–1017. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Park HS, Bae JS, Jang KY, Lee JH, Yu HC,
Jung JH, Cho BH, Chung MJ and Moon WS: Clinicopathologic study on
combined hepatocellular carcinoma and cholangiocarcinoma: with
emphasis on the intermediate cell morphology. J Korean Med Sci.
26:1023–1030. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nzeako UC, Goodman ZD and Ishak KG:
Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A
clinico-histopathologic study of 804 North American patients. Am J
Clin Pathol. 105:65–75. 1996.
|
|
18
|
Nakanuma Y and Ohta G: Is mallory body
formation a preneo-plastic change? A study of 181 cases of liver
bearing hepatocellular carcinoma and 82 cases of cirrhosis. Cancer.
15:2400–2404. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nakashima O, Sugihara S, Eguchi A, Taguchi
J, Watanabe J and Kojiro M: Pathomorphologic study of pale bodies
in hepato-cellular carcinoma. Acta Pathol Jpn. 42:414–418.
1992.PubMed/NCBI
|
|
20
|
Nayar R, Bourtsos E and DeFrias DV:
Hyaline globules in renal cell carcinoma and hepatocellular
carcinoma. A clue or a diagnostic pitfall on fine-needle
aspiration? Am J Clin Pathol. 114:576–582. 2000. View Article : Google Scholar : PubMed/NCBI
|
